Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development Process with Dr Kert Viele

Apr 2, 202005:04Health

Ed Livingston, MD, FACS, AGAF, discusses Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development Process with Kert Viele, PhD

Related Episodes

Continue listening to more episodes from JAMAevidence Users' Guide to the Medical Literature: Using Evidence to Improve Care.

Feb 5, 2026 - 17:05

Toshi A Furukawa, MD, PhD, Kyoto University, Graduate School of Medicine, School of Public Health, discus...

Oct 2, 2025 - 14:58

Thomas Agoritsas, MD, PhD, Geneva University Hospitals, Switzerland discusses Users' Guides to the Medica...

May 1, 2025 - 14:52

Mark C. Wilson, MD, MPH, University of Iowa, Carver College of Medicine discusses Evidence-Based Practiti...

Oct 3, 2024 - 14:56

Mark C. Wilson MD, MPH, University of Iowa, discusses Teachers' Guides to the Users' Guides with Gordon H...

Oct 5, 2023 - 15:55

Gordon H. Guyatt, MD, MSc, discusses Assessing the Strength of Recommendations: The GRADE Approach with P...

Sep 7, 2023 - 16:27

Host Gordon Guyatt, MD, MSc, discusses Understanding and Applying the Results of a Systematic Review with...

Jul 6, 2023 - 20:30

Gordon H. Guyatt, MD, MSc, discusses Fixed-Effects and Random-Effects Models with M. Hassan Murad, MD. Re...

Feb 2, 2023 - 17:22

Gordon H. Guyatt, MD, MSc, discusses Adjusted Analyses in Studies Addressing Therapy and Harm with Thomas...